Ephrin type-A receptor 3
Ephrin type-A receptor 3 (356-367) is a synthetic peptide fragment derived from the ephrin receptor A3, a member of the Eph family of receptor tyrosine kinases. This specific peptide sequence encompasses amino acids 356 to 367 of the parent protein, representing a biologically relevant domain often implicated in protein-protein interaction studies. As ephrin signaling plays a pivotal role in processes such as cell positioning, axon guidance, and tissue patterning, this peptide serves as a valuable tool for dissecting the molecular mechanisms underlying Eph receptor function. Its defined sequence and biochemical properties make it particularly suitable for research applications that require precise modulation or mapping of ephrin receptor-mediated pathways.
Receptor-ligand interaction studies: The 356-367 fragment of Ephrin type-A receptor 3 is commonly employed in binding assays to elucidate the interaction dynamics between EphA3 and its ephrin ligands. By using this peptide as a competitive inhibitor or probe, researchers can investigate the specificity and affinity of ephrin binding sites, enabling the characterization of critical contact residues and mapping of functional domains within the receptor. Such studies are essential for understanding the structural basis of receptor activation and downstream signaling events.
Signal transduction analysis: In cellular and biochemical assays, the synthetic peptide corresponding to the 356-367 region can be used to modulate EphA3-mediated signaling pathways. Introduction of this peptide into cell cultures or in vitro systems allows for the assessment of its impact on autophosphorylation, downstream effector recruitment, and the broader signaling cascade. These approaches provide valuable insights into the regulatory mechanisms governing cell adhesion, migration, and cytoskeletal reorganization orchestrated by Eph receptors.
Epitope mapping and antibody development: The defined sequence of this peptide fragment makes it an ideal candidate for epitope mapping applications. Researchers frequently utilize such peptides to generate and validate site-specific antibodies targeting the EphA3 receptor. These antibodies can then be applied in immunoassays, western blotting, or immunoprecipitation experiments to detect or quantify receptor expression, monitor post-translational modifications, or study receptor localization in various biological samples.
Peptide-based inhibitor screening: The 356-367 peptide can serve as a template or reference in the design and screening of small-molecule or peptide-based inhibitors targeting the EphA3 receptor. By evaluating the ability of candidate compounds to disrupt peptide-mediated interactions or receptor activation, researchers can identify novel modulators of ephrin signaling. This approach is particularly relevant in the context of high-throughput screening platforms aimed at discovering new research probes or chemical tools for pathway dissection.
Structural and conformational studies: The availability of a synthetic peptide corresponding to a specific functional domain of EphA3 facilitates detailed structural analyses using techniques such as NMR spectroscopy or X-ray crystallography. These studies can reveal the conformational preferences, folding characteristics, or interaction surfaces of the peptide, contributing to a deeper understanding of receptor architecture and the molecular determinants of ligand recognition. Such structural insights are instrumental in guiding rational design of targeted research reagents and advancing knowledge of Eph receptor biology.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More